跳至主要内容
临床试验/IRCT201011075117N1
IRCT201011075117N1已完成未知

Zonisamide versus Topiramate in migraine prophylaxis: a double-blind randomized clinical trial

Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 65 years(—)
性别
All

入选标准

  • history of classic or common migraine that met International Headache Society (HIS) criteria, which is at least one year of past disease, number of migraine attacks at least four times per month and less than 15 times per month, or even when they occur less than four times per month but migraine attacks are very prolonged and debilitating that require preventive treatment, postmenopausal women who pass at least one year of their menopause, negative pregnancy test, using appropriate contraceptive during the study, no consumption of topiramate or Zonisamide
  • Exclusion criteria: suffering from other than migraine headaches such as tension headaches, periodic headaches and sinusitis, presence of any cause of pain that must be used medications regularly, history of hypersensitivity to topiramate or zonisamide

排除标准

  • 未提供

研究者

相似试验